Antech, Royal Canin share cat food solution supporting kidney health

LAS VEGAS – On September 7th, Antech Diagnostics and Royal Canin announced a new preventive nutrition solution to pet owners to complement RenalTech ™, an advanced diagnostic tool that can predict chronic kidney disease (CKD) in cats up to two years before it occurs kidney disease in cats is supposed to help.

The solution, Renal Support Early Consult, was described by Royal Canin as “an early intervention strategy” during a training session at the WVC annual conference on Tuesday. The diet complements Antech’s diagnostic capabilities to create a well-rounded and proactive plan for pet owners dealing with CKD in cats.

“The ability to predict disease opens a new pathway for CRF treatment in cats that represents an improved standard of care,” said Todd East, DVM, director of veterinary affairs at Royal Canin. “This new path includes increased engagement between veterinarians, pet owners and pets through more regular veterinary visits, the ability to monitor kidney levels over time, and now a special diet designed specifically for early CRF and with veterinary approval from Royal Canin is available for predicting a brighter future for cats and their humans. “

Renal Support Early Consult is a high-calorie and nutrient-rich formula that stimulates appetite, regulates phosphorus levels, provides special antioxidants and fatty acids from fish oil, and provides targeted protein levels to support healthy kidney function.

“RenalTech is having an overwhelmingly positive impact on the way veterinarians are treating chronic kidney disease in cats – and wanting to treat pet owners,” said Jennifer Ogeer, DVM, vice president of medical science and innovation at Antech. “Now that veterinarians can predict disease outbreaks up to two years before it occurs, we urgently need new strategies for early care. Diet changes are one of the most effective approaches, and the Antech and Royal Canin approach is specifically designed to make veterinarians stand out To offer performance. ” Opportunity to support the best possible outlook for cats faced with a disease. “

Antech first launched RenalTech in October 2019. The solution uses artificial intelligence and veterinary records to accurately predict CKD in cats, which is the leading cause of death in cats over 5 years old and affects up to 40% of cats over 10 years old.

Jennifer Lopez, DVM, from Antech, and Adrienne Bautista, DVM, Ph.D., from Royal Canin presented the nutritional solution at the WVC conference. Those who attended the WVC Annual Conference will have access to an on-demand replay of the presentation entitled “CKD, You Don’t Know Me: Prediction, Diagnosis and Nutritional Management in Partnership with Royal Canin.”

Read more about product development, ingredients and formulation.